Send me a link:

*Text messaging rates may apply.

 Dow Up0.13% Nasdaq Down0.10%

Oxygen Biotherapeutics, Inc. (OXBT)

-NasdaqCM
3.97 0.03(0.76%) Jul 28, 3:59PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJan 31, 2014Oct 31, 2013Jul 31, 2013Apr 30, 2013
Total Revenue 42   59   193   208  
Cost of Revenue0  3  28  27  
Gross Profit 42   56   166   182  
Operating Expenses
Research Development690  749  773  845  
Selling General and Administrative1,784  1,421  983  549  
Non Recurring -   -   -  27  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (2,431) (2,114) (1,590) (1,239)
Income from Continuing Operations
Total Other Income/Expenses Net(850)(0)0  3  
Earnings Before Interest And Taxes(3,281)(2,115)(1,589)(1,236)
Interest Expense70  1,417  656  623  
Income Before Tax(3,351)(3,531)(2,245)(1,859)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(3,351)(3,531)(2,245)(1,859)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (3,351) (3,531) (2,245) (1,859)
Preferred Stock And Other Adjustments(1,097)(2,551)(2,095)(958)
Net Income Applicable To Common Shares (4,448) (6,082) (4,340) (2,817)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.